Keyhaler (DPI) Franchise Company – Your presence on this page clearly defines your intentions. You’re looking for a reliable Keyhaler franchise company to venture into this profitable segment. To be more specific, you have marked the right place. Luckys Pharma is a fully encompassed pharmaceutical company to meet your needs professionally.
Luckys Pharma deals with a wide spectrum of medicinal services and products. It is catering to the industry needs and the healthcare sector using well-authenticated technologies and procedures. Established in 2001, Luckys Pharma is a perfect choice for business associates who want to invest in the Keyhaler devices segment.
What is Keyhaler?
Simply put, a Keyhaler is a plastic device designed for DPI capsules. It is used to consume the medicine through a dry powder inhaler. The medicine in the form of dry powder is said to deliver in a special inhaler. Dry powder inhalers and keyhaler fall in the same category since both are used for the same purpose.
Further, these portable machines are specifically designed for patients with severe asthma conditions or COPD. These patients need to take the medicine through the respiratory system. It is the easiest way to cultivate the full credit of the medicine as it runs directly through the lungs, instead of the blood circulation.
How to Use?
Asthma inhalers are portable and compact devices to provide medication to the lungs. When it comes to controlling asthma symptoms, inhalers are be productive solution. However, one needs to be vigilant while choosing the right product as prescribed by the physician.
To ensure you get the most out of it, you must be familiar with the right way of use. Before you put it to the final use, make sure you have sterilized the device thoroughly. Further, open the top part of it and fill the medicine inside. Now, insert the sharp end into the mouth and breathe heavily via the mouth. Make sure you feel the full impact of the medicine on your lungs for proper effect.
Keyhaler DPI Device Market in India
With the ever-growing pollution levels, the number of asthma patients is increasing every single day. As per reports, India is home to 2% of adults and 5% of children with asthma among the whole population. According to estimates, one in every 10 asthma patients in the world is in India.
According to reports of five years, dust, pollens, and cockroaches are the major reasons for allergic asthma. Hence, one can estimate the overall onslaught of the pandemic across the nation.
Given the prevailing scenarios, the keyhaler market is expected to grow drastically in India in the coming years. Eventually, the demand for dry powder inhalers tends to multiply accordingly. New enterprises have a gargantuan scope for business in this corridor.
Demand for the Keyhaler Franchise in India
Many people have respiratory issues; thus, it’s critical to get the appropriate consultation for respiratory health issues. It has been demonstrated that keyhalers work well for treating respiratory disorders. Keyhaler has become more and more popular in India recently. And all of this is a result of the rising prevalence of COPD and asthma. According to the global poll, this is true everywhere, not only in India. Patients now find it much easier, thanks to the development of these inhalers.
Market Segment for Keyhaler in India
| Market Size | USD 112 Billion |
| Year 2023 | USD 29.9 Billion |
| Year 2024 | USD 31.19 Billion |
| Year 2033 | USD 50.80 Billion – approx. |
| CAGR | 4.9% |
| Market Forecast Period | 2023 – 2033 |
| Segments | Product Type, Region, Users, and Factors |
| Geographical area covered | North America, Asia, Asia Pacific, South Africa, and other parts of the world |
| Opportunities | It is expected that there will be an increased demand for respiratory inhalers in the future, so companies need to increase production to cover the increasing demand. |
The production of the best product for the consumer is significant while increasing the respiratory inhaler sector. In 2020, 3.9 million people lost their lives due to asthma and other respiratory diseases, and this figure is still increasing day by day. The need for the medicine results from the increasing respiratory complications linked with COPD.
Why Should You Partner with Luckys Pharma for Keyhaler Franchise Services?
As we have already talked about, beginners come to enjoy massive space and growth opportunities in the keyhaler DPI wing. In case you’re new to the industry and looking for a trustworthy brand to proceed with, here’s the answer for you.
Luckys Pharma is a fully-fledged pharmaceutical company serving customers and business associates comprehensively. It offers a myriad of medical products and equipment under diverse categories. Keyhaler is one of the well-in-demand devices in the market, given the dominating influence of asthma disease.
The following are various fronts Luckys Pharma stands out:
- Luckys Pharma is amongst the most experienced players in the Indian pharmaceutical sector.
- Further, it deals with a variety of pharma products from the same counter. You can approach the brand for capsules, rotacaps, nasal spray, tablets, injectables, syrups, keyhalers, and other products.
- All of the medical products are formulated using advanced manufacturing technologies and tactics. It executes quality-rich raw materials to ensure the best products are achieved.
- Luckys Pharma is surely the best keyhaler franchise company as it stresses the quality concerns promptly. It follows the WHO guidelines strictly and tries to meet the top-notch quality standards.
- Furthermore, the company offers third-party manufacturing and PCD franchise services to new startups.
- Pricing is another notable factor that makes Luckys Pharma worth considering.
- The firm involves a team of qualified scientists, researchers, and marketers who ensure the best practices are followed and maintained.
Contact Details
Company Name: Luckys Pharma
Address: Plot No. 82, 1st Floor, Jaora Compound, Near Police Lines, Indore – 452001, Madhya Pradesh, India
Contact: 08889909734, 08889909733, 09425063976
Email: luckyspharma@gmail.com
FAQs About Keyinhalers
Q1. What is the total market size of Keyhaler?
A- The total market size of the keyhaler and respiratory inhalers is expected to be approx. USD 113 Billion.
Q2. At what growth rate is the market of respiratory inhalers increasing?
A- Expected growth rate of CAGR 4.9% and an increase in the upcoming years.
